Hercules Capital (HTGC) is back in the spotlight after closing an upsized offering of $400 million in 6.700% senior unsecured notes due 2029, a funding move closely watched by income focused investors.
Recent trading tells a mixed story. Hercules Capital’s share price has slipped over the past month, with a 30 day share price return of 6.3% down and year to date performance also weaker, yet longer term total shareholder returns of 11.0% over one year and 67.1% over five years point to momentum that has built over time. The upsized 6.700% note offering fits into this backdrop as investors weigh fresh funding flexibility against a recent 7 day share price return of 1.4% down and a 90 day share price return of 3.1% up from the US$16.51 level.
Spot fresh opportunities by comparing Hercules Capital’s latest funding move with income focused lenders on our hand picked 8 dividend fortresses list.Hercules Capital now trades at a clear discount to both analyst targets and one estimate of fair value, even after locking in 6.700% funding. Is that caution sensible, or has the market pushed too far?
The widely followed Hercules Capital narrative pegs fair value at $19.50, which sits above the recent $16.51 close, so the funding news is dropping into a story that already assumes a discount and solid earnings power from the existing platform.
Sustained expansion in Hercules Capital's technology and life sciences verticals, reflected in record first half 2026 originations of US$2.74b and record fundings of US$1.35b, continues to support visibility on future total investment income and net investment income growth.
See why 62 investors see Hercules Capital as 15% undervalued.
Result: Fair Value of $19.50 (UNDERVALUED)
Still, Hercules Capital’s heavy tilt to technology and life sciences, together with relatively high leverage and new fixed interest costs, could quickly test that 15.3% undervalued narrative.
Find out about the key risks to this Hercules Capital narrative.
There are mixed messages in the Hercules Capital story so far. Act while the data is fresh, review the key details, then weigh the 3 key rewards and 2 important warning signs.
Do not stop with Hercules Capital alone. Use the Simply Wall Street Screener to compare fresh ideas, spot patterns faster, and keep your watchlist one step ahead.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com